Sponsors

Mycoplasma pneumoniae monoclonal antibodies

Mycoplasma pneumoniae is a parasitic pathogen of the human respiratory tract. This bacterium lacks a cell wall and thus many antibiotics that inhibit cell wall synthesis are ineffective as treatment. M. pneumoniae causes atypical pneumonia and affects children and young adults most commonly. The organism adheres to respiratory epithelial cells via several adhesins. The P1 adhesin is a major virulence factor of this organism.

ViroStat has now released a new set of monoclonal antibodies to the P1 adhesin of M. pneumoniae. These new antibodies function well in immunofluorescence antibody (IFA) staining and as enzyme-linked immunosorbent assay (ELISA) pairs for the detection of the P1 antigen. These antibodies join the existing collection of ViroStat M. pneumoniae antibody reagents.
www.virostat-inc.com

Latest Issues

Microbiology Society Annual Conference 2025

Liverpool Arena and Convention Centre
31 March - 3 April, 2025

2nd Global Summit on Pathology

Rome, Italy
10-11 April, 2025

The 10 Year Plan - Clinical Innovations Expo

Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025

Transforming Digital Pathology & AI: The Path Forward

Royal College Of Physicians Of Edinburgh
15 May, 2025

BSMT 40th Anniversary Microbiology Conference

RAF Museum, Hendon, London NW9 5LL
15 May, 2025